CN1077384A - The manufacture method of willow-dandelion tablet for preventing hepatitis - Google Patents
The manufacture method of willow-dandelion tablet for preventing hepatitis Download PDFInfo
- Publication number
- CN1077384A CN1077384A CN 93101064 CN93101064A CN1077384A CN 1077384 A CN1077384 A CN 1077384A CN 93101064 CN93101064 CN 93101064 CN 93101064 A CN93101064 A CN 93101064A CN 1077384 A CN1077384 A CN 1077384A
- Authority
- CN
- China
- Prior art keywords
- willow
- tablet
- hepatitis
- manufacture method
- dandelion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is a kind of manufacture method that is used for prophylactic willow-dandelion tablet for preventing hepatitis.It consists of five tastes effective ingredient such as Ramulus Salicis Babylonicae, Herba Taraxaci, Radix Isatidis, Herba Artemisiae Scopariae, Herba Plantaginis and the processing and manufacturing of starch auxiliary element becomes tablet, and is oral.Be used for the prophylactic treatment infectious hepatitis, have lot of data that its effect is described.
Description
The present invention is that a kind of manufacture method of prophylactic willow-dandelion tablet for preventing hepatitis belongs to pharmaceutical sanitary field.
Viral hepatitis is the acute infectious disease that is caused by hepatitis virus, the commonly encountered diseases of serious harm people ' s health and frequently-occurring disease, and primary disease now divides first type and B-mode two classes.But these two kinds of hepatitis are per os and blood propagation all.In daily life the street restaurant and the family cooking food person and drink trencherman ill or in spite of illness poison have a meal together, illness finds its way in by the mouth and cause that it is very common that family or collective unit supervention case person occurs by close contact.On blood, can both infect with lancet etc. as syringe, operating theater instruments, chemical examination.Blood is handled, water, food and enter the mouth, and also is approach of important propagation etc.At present the prevention of this disease still there is not effective method.Be used to prevent antiviral therapy with the prepared from traditional Chinese medicines tablet.Do not report both at home and abroad.
Task of the present invention is the occurrence regularity at China's viral hepatitis, utilizes secret recipe research to come the infection prevention hepatitis with Chinese herbal medicine.Promptly with Chinese medicine medicines such as Ramulus Salicis Babylonicae, Herba Taraxaci, Radix Isatidis, Artemisia anethoicles Mattf, Herba Plantaginis through processing and manufacturing, make tablet, orally play effects such as prevention, antiviral and treatment.
Details are as follows for the manufacture method of willow-dandelion tablet for preventing hepatitis of the present invention:
1, raw material:
(1) willow branch and leaf (dry product) (can separate the stagnation of liver-QI antiviral, removing heat from the liver enlivens liver cell, helps the restitution of liver function)
(2) Herba Taraxaci (energy heat-clearing and toxic substances removing, eliminating stagnation, antibiotic, antivirus action)
(3) Radix Isatidis (energy heat-clearing and toxic substances removing, removing heat from blood the liver benefiting, sterilizing and anti-virus effect)
(4) Artemisia anethoicles Mattf (energy clearing away heat-damp and promoting diuresis, antivirus action)
(5) Herba Plantaginis (energy antiviral, the effect of detoxifcation the liver benefiting)
(6) starch (or rice flour, flour play adhesive effect)
Above raw material is standby with 100-120 purpose sieve
2, configuration proportion:
The five tastes play the match ratio of the Chinese herbal medicine of therapeutical effect and for example descend (weight ratio):
Willow Laurus nobilis 30%
Herba Taraxaci 30%
Radix Isatidis 25%
Herba Plantaginis 15%
Herbal raw material=five tastes play the Chinese herbal medicine+starch of therapeutical effect
Medicated powder shape raw material: water 1: 1
3, preparation steps:
Raw material weighed to be added in above cooperation ratio to be mixed together evenly, medicated powder is added in the water to stir evenly earlier, and starch (or rice flour, flour) 15% is added evenly, puts into pot and is heated into pasty state with 40 °-70 °.With the tabletting machine tabletting of making tablet, every heavy 0.5 restrains then.
Below be method and effect with willow-dandelion tablet for preventing hepatitis prevention and treatment viral hepatitis:
1, two cities treat infectious hepatitis 67 examples with willow-dandelion tablet for preventing hepatitis in Changshu, Wuxi in March, 1988, the paddy third ammonia enzyme is all reduced to normally after one month.All do not prevent with willow-dandelion tablet for preventing hepatitis suffering from infectious hepatitis simultaneously, JIUYUE is carried out the hepatitis generaI investigation.Do not find hepatitis patient.The same period, there are hepatitis 16 examples in the Qian Qiao town, and with the willow-dandelion tablet for preventing hepatitis treatment, the transaminase all drops to normally in one month.Do to take and do not take willow-dandelion tablet for preventing hepatitis at two units again and observe, the result does not find hepatitis 3 examples with a unit of the anti-liver sheet of Liu Pu, and there is not morbidity in the unit of taking willow-dandelion tablet for preventing hepatitis.
Prevention and Therapeutic Method are once oral weekly to prevention hepatitis, and each 2, oral twice to treating hepatitis every day, each 1,28 is a course of treatment.
Claims (2)
1, the manufacture method of the willow-dandelion tablet for preventing hepatitis of a kind of main prevention and treatment infection hepatitis is characterized in that:
(1) raw material ratio:
The Chinese herbal medicine that the five tastes play prevention and therapeutical effect cooperates ratio (weight portion) as follows:
Willow branch and leaf (dry product) 30%, Herba Taraxaci 30%, Radix Isatidis 25%, Herba Plantaginis 15%.
Herbal raw material=five tastes play the Chinese herbal medicine+starch (or rice flour) of therapeutical effect.
(2) compound method:
Five tastes Chinese herbal medicine is processed into powder through 100-120 purpose sieve, sieves.
Ramulus Salicis Babylonicae 30%, Herba Taraxaci 30%, Baphicacanthus cusia bucket 25%, Herba Plantaginis 15% is added in water Chinese medicine powder and water and stirs evenly at 1: 1 with starch (or rice flour) 15% adding evenly, puts into pot with 40 °-70 °, is heated into pasty state, and then with the machine tabletting of making tablet, every heavy 0.5 restrains.
2, the manufacture method of willow-dandelion tablet for preventing hepatitis according to claim 1 is characterized in that in the described batch, and batching can add starch (or rice flour, flour) addition and be about 15% of Total Water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93101064 CN1077384A (en) | 1993-01-20 | 1993-01-20 | The manufacture method of willow-dandelion tablet for preventing hepatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93101064 CN1077384A (en) | 1993-01-20 | 1993-01-20 | The manufacture method of willow-dandelion tablet for preventing hepatitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1077384A true CN1077384A (en) | 1993-10-20 |
Family
ID=4983391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93101064 Pending CN1077384A (en) | 1993-01-20 | 1993-01-20 | The manufacture method of willow-dandelion tablet for preventing hepatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1077384A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1067888C (en) * | 1997-01-24 | 2001-07-04 | 殷国健 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
| US7381435B2 (en) * | 2003-03-05 | 2008-06-03 | Original Image Co., Ltd. | Composition for treating hepatitis C |
-
1993
- 1993-01-20 CN CN 93101064 patent/CN1077384A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1067888C (en) * | 1997-01-24 | 2001-07-04 | 殷国健 | 'Ganyankang' oral liquid-for treating hepatitis and preparation method |
| US7381435B2 (en) * | 2003-03-05 | 2008-06-03 | Original Image Co., Ltd. | Composition for treating hepatitis C |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ampofo | Plants that heal | |
| CN1170597A (en) | Eczema pill | |
| CN1767845A (en) | Composition for treating hepatitis c | |
| CN1077384A (en) | The manufacture method of willow-dandelion tablet for preventing hepatitis | |
| US5980903A (en) | Composition for the treatment of viral infections including HIV | |
| CN1016141B (en) | Preparation method of new type sanguisorba pharmaceutical | |
| CN1050051C (en) | "Dianjiankang" - a Chinese proprietary medicine for treatment of epilepsy | |
| CN1473604A (en) | Capsule for treating epidemic parotitis | |
| CN1582989A (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN1299732C (en) | Chinese medicine preparation for treating fatty liver | |
| CN1056071C (en) | Hepatitis virus inhibitor and prepn. method thereof | |
| CN1173725C (en) | Chinese patent medicine for treating thyroidism and simple thyrocele and its preparing process | |
| US6582733B1 (en) | Composition for the treatment of hepatitis including HCV | |
| CN1195541C (en) | Medicine combination for treating chronic hepatitis B | |
| CN1097139A (en) | The compounded solid oral medicine of treatment upper respiratory tract infection | |
| CN1169872A (en) | Chinese medicine preparation for icterus and liver health | |
| CN102614467A (en) | Traditional Chinese medical composition for treatment of acquired immunodeficiency syndrome and preparation method and application thereof | |
| CN1041992C (en) | Preparation technology of cold resistant panacla tablet | |
| CN1899416A (en) | Chinese medicine composition for treating rheumatism and its use | |
| CN107802681B (en) | Composition for improving clinical symptom sign of HIV infected person | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| EA009393B1 (en) | Pharmaceutical composition which can be used, for example, as an antiviral or antibacterial agent and to stimulate immune defences | |
| CN1049120C (en) | Chinese traditional drug head-ache tablet | |
| CN1183288A (en) | Yiai pill (powder) and method for manufacturing same | |
| CN1589834A (en) | Liver safeguarding pill |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |